Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on March 8, 2021. The filing serves to announce the Company's financial results for the period ended December 31, 2020, and provides an update on recent corporate events. The detailed results are contained in a press release and a letter to stockholders furnished as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached Exhibits 99.1 and 99.2 but are not present in the body of this 8-K filing.
Material Changes
The filing indicates that material financial results for the year ended December 31, 2020, have been released. However, the text does not specify the nature or magnitude of changes compared to prior periods.
Guidance, Outlook, and Risks
The Company issued a press release and a letter to stockholders regarding its outlook and recent events. The filing explicitly states that the information furnished under Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section. Furthermore, the Company does not assume any obligation to update the information contained in the exhibits in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the year ended December 31, 2020.
- Examine Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and management commentary.
- Verify the Company's liquidity position and debt obligations as detailed in the attached exhibits, as they are not listed in this summary text.
- Note that the information in this 8-K is not incorporated by reference into other filings unless specifically stated.